Geron reported $50.18M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Amgen AMGN:US $ 36854M 3545M
Bio Techne TECH:US $ 259.01M 23.1M
Cti Biopharma CTIC:US $ 106.33M 58.95M
Cytokinetics CYTK:US $ 197.98M 55.14M
Esperion Therapeutics ESPR:US $ 258.68M 398K
Exelixis EXEL:US $ 0M 0M
Genmab GEN:DC DK 416M 9M
Geron GERN:US $ 50.18M 0.35M
Gilead Sciences GILD:US $ 26208M 487M
Macrogenics MGNX:US $ 0M 0M
Novartis NOVN:VX SF 31275M 250M
Novavax NVAX:US $ 440.5M 13.49M
Pain Therapeutics PTIE:US $ 0M 0M
Seattle Genetics SGEN:US $ 0M 0M
YTE INCY:US $ 34.18M 0.09M